XCR Diagnostics, Inc. was founded in 2015 with focus on Molecular Diagnostic Infectious Diseases. XCR has a disruptive medical diagnostics device that displaces existing technology. 4th generation Nucleic Acid Chemistry, Sample prep/amplification/ detection. Including COVID 19! "We are raising $1.5M to obtain fast track FDA approval for our molecular diagnostic point of care Covid-19 and many other infectious diseases testing device"